Trial intelligence / Profile preview

PARROT-Junior azithromycin prophylaxis trial in young children with neurological impairment

ACTRN12621001486819Phase 4Completed

Sponsor
Menzies School of Health Research
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in pulmonary infection comparing Azithromycin with Placebo (2 arms). Primary endpoint: Rate of lower respiratory tract infections. Started Dec 2021; status: completed.

02

Drugs

azithromycin
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on ACTRN12621001486819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621001486819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call